Cytomegalovirus infection in bone marrow transplant recipients: use of intravenous gamma globulin as a prophylactic and therapeutic agent
Kapoor, N.; Copelan, E.A.; Tutschka, P.J.
Transplantation Proceedings 21(1 Part 3): 3095-3096
1989
ISSN/ISBN: 0041-1345 PMID: 2539686 Document Number: 344457
Document emailed within 1 workday
Related Documents
Winston, D.J.; Ho, W.G.; Lin, C.H.; Bartoni, K.; Budinger, M.D.; Gale, R.P.; Champlin, R.E. 1987: Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation Annals of Internal Medicine 106(1): 12-18Bonaros, N.E.; Kocher, A.; Dunkler, D.; Grimm, M.; Zuckermann, A.; Ankersmit, J.; Ehrlich, M.; Wolner, E.; Laufer, Günther. 2004: Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients Transplantation 77(6): 890-897
Peraldi, M.N.; Rondeau, E.; Bellaj, A.; Kanfer, A.; Sraer, J.D. 1988: Association of cytomegalovirus infection and immunosuppressive treatment with cyclosporine A and antilymphocyte globulin in renal transplant recipients Clinical Nephrology 29(1): 52
Pollard, R.B.; Merigan, T.C. 1978: Perspectives for the control of cytomegalovirus infections in bone marrow transplant recipients Transplantation Proceedings 10(1): 241-245
Bosi, A.; De Majo, E.; Guidi, S.; Parri, F.; Saccardi, R.; Vannucchi, A.M.; Fanci, R.; Ferrini, P.R. 1990: Kinetics of anti-CMV antibodies after administration of intravenous immunoglobulins to bone marrow transplant recipients Haematologica 75(2): 109-112
Goto, H.; Yuasa, K.; Sakamaki, H.; Nakata, K.; Komuro, I.; Iguchi, M.; Okamura, T.; Ieki, R.; Tanikawa, S.; Akiyama, H.; Onozawa, Y.; Mochida, Y. 1996: Rapid detection cytomegalovirus pneumonia in recipients of bone marrow transplant: evaluation and comparison of five survey methods for bronchoalveolar lavage fluid Bone Marrow Transplantation 17(5): 855-860
Whimbey, E.; Champlin, R.E.; Englund, J.A.; Mirza, N.Q.; Piedra, P.A.; Goodrich, J.M.; Przepiorka, D.; Luna, M.A.; Morice, R.C.; Neumann, J.L. 1995: Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients Bone Marrow Transplantation 16(3): 393-399
Fries, B.C.; Khaira, D.; Pepe, M.S.; Torok-Storb, B. 1993: Declining lymphocyte counts following cytomegalovirus (CMV) infection are associated with fatal CMV disease in bone marrow transplant patients Experimental Hematology 21(10): 1387-1392
Shinohara, K.; Tanaka, M.; Matsuda, M.; Tanaka, H.; Fujii, Y.; Yamada, K.; Kaneko, T. 1990: Gamma interferon production and two-color fluorescence flow cytometry analysis of peripheral blood mononuclear cells in allogeneic bone marrow transplant recipients Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 53(1): 76-83
Cooper, M.H.; Maraninchi, D.; Gastaut, J.A.; Mannoni, P.; Carcassonne, Y. 1993: HIV infection in autologous and allogeneic bone marrow transplant patients: a retrospective analysis of the Marseille bone marrow transplant population Journal of Acquired Immune Deficiency Syndromes 6(3): 277-284
Gondo, H. 1998: Cytomegalovirus infection in transplant recipients Nihon Rinsho. Japanese Journal of Clinical Medicine 56(1): 173-178
Lehn, P.; Quessar, A.; Devergie, A.; Esperou-Bourdeau, H.; Traineau, R.; Trédaniel, J.; Benbunan, M.; Bussel, A.; Jolivet, I.; Mazeron, M.C. 1990: Treatment of severe cytomegalovirus infection with ganciclovir and high-dose intravenous immunoglobulin in patients with allogeneic bone marrow transplants. a pilot study Nouvelle Revue Francaise d'Hematologie 32(1): 17-20
Sivathasan, C.; Doraisingham, S.; Ling, A.E.; Ng, A.; Allen, D.M.; Tong, M.C. 1992: Is cytomegalovirus infection going to be a problem among heart transplant recipients in Singapore? Transplantation Proceedings 24(5): 2019-2021
Winston, D.J.; Meyer, D.V.; Gale, R.P.; Young, L.S. 1978: Further experience with infections in bone marrow transplant recipients Transplantation Proceedings 10(1): 247-254
Yuen, K.Y.; Woo, P.C.; Tai, J.W.; Lie, A.K.; Luk, J.; Liang, R. 2001: Effects of clarithromycin on oral mucositis in bone marrow transplant recipients Haematologica 86(5): 554-555
Leigh, S.; Wilson, K.C.; Burns, R.; Clark, R.E. 1995: Psychosocial morbidity in bone marrow transplant recipients: a prospective study Bone Marrow Transplantation 16(5): 635-640
Rostaing, L.; Baron, E.; Fillola, O.; Roques, C.; Durand, D.; Massip, P.; Lloveras, J.J.; Suc, J.M. 1995: Toxoplasmosis in two renal transplant recipients: diagnosis by bone marrow aspiration Transplantation Proceedings 27(2): 1733-1734
Siennicka, J.; Durlik, M.; Litwińska, B.; Chmura, A.; Lewandowska, D.; Lao, M.; Paczek, L.; Kańtoch, M. 1999: Identification of cytomegalovirus (CMV) infection by different laboratory methods in renal transplant recipients undergoing triple-drug immunosupressive treatment Acta Microbiologica Polonica 48(1): 61-71
Gorski, J.; Yassai, M.; Keever, C.; Flomenberg, N. 1995: Analysis of reconstituting T cell receptor repertoires in bone marrow transplant recipients Archivum Immunologiae et Therapiae Experimentalis 43(2): 93-97
Metselaar, H.J.; Velzing, J.; Rothbarth, P.H.; Simoons, M.L.; Bos, E.; Weimar, W. 1987: A pharmacokinetic study of anti-cytomegalovirus hyperimmunoglobulins in cytomegalovirus seronegative cardiac transplant recipients Transplantation Proceedings 19(5): 4063-4065